June 14, 2021 -- Twist Bioscience is collaborating with Regeneron subsidiary Regeneron Genetics Center to launch a custom next-generation sequencing (NGS) population genetics genotyping assay.
The Twist Diversity SNP Panel will help users determine disease mechanisms, identify drug targets, and speed drug development, according to the firm. The panel includes 1.4 million genetic variations called single-nucleotide polymorphisms (SNPs) and is the company's first release in its Targeted Genotyping-By-Sequencing portfolio, Twist said.
Twist said it plans to immediately begin marketing the assay under the Regeneron agreement.